Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    22343727 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Rituximab and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Hodgkin's Lymphoma
Condition: Lymphoma
Interventions: Biological: bleomycin;   Biological: rituximab;   Drug: ABVD regimen;   Drug: dacarbazine;   Drug: doxorubicin;   Drug: vinblastine;   Genetic: DNA methylation analysis;   Other: laboratory biomarker analysis;   Radiation: fludeoxyglucose F 18

Study has passed its completion date and status has not been verified in more than two years.